MedicaidBilling CodesMedium impact

Medicaid Alert MA-2022-02

Q: Who is affected by this change?

This affects New Jersey Medicaid Infectious Disease, Internal Medicine, Family Medicine providers in NJ on Medicaid plans.

New Jersey Medicaid·NJ · Infectious Disease, Internal Medicine, Family Medicine·Coding

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

New Jersey Medicaid has established a new billing procedure for Cabenuva® (cabotegravir and rilpivirine) administration. This fresh policy update requires immediate implementation of revised billing protocols for this HIV medication administration.

Action Required

Action needed

Immediately: Billing team must review and implement the new Cabenuva® administration billing procedure outlined in policy MA-2022-02. Download the full policy document from the NJ MMIS website to understand specific billing requirements. Update billing protocols and staff training for this HIV medication administration procedure.

Related policy hubs

New Jersey Medicaid policies NJ policy changes Infectious Disease Internal Medicine Family Medicine